ES2117014T3 - Quinazolinonas substituidas en las posiciones 2,3,6 bloqueadoras del receptor de la angiotensina ii. - Google Patents
Quinazolinonas substituidas en las posiciones 2,3,6 bloqueadoras del receptor de la angiotensina ii.Info
- Publication number
- ES2117014T3 ES2117014T3 ES92100640T ES92100640T ES2117014T3 ES 2117014 T3 ES2117014 T3 ES 2117014T3 ES 92100640 T ES92100640 T ES 92100640T ES 92100640 T ES92100640 T ES 92100640T ES 2117014 T3 ES2117014 T3 ES 2117014T3
- Authority
- ES
- Spain
- Prior art keywords
- angiotensin
- elevated
- quinazolinones
- receiver
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Manufacture Of Tobacco Products (AREA)
- Fats And Perfumes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64849291A | 1991-01-30 | 1991-01-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2117014T3 true ES2117014T3 (es) | 1998-08-01 |
Family
ID=24601009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92100640T Expired - Lifetime ES2117014T3 (es) | 1991-01-30 | 1992-01-16 | Quinazolinonas substituidas en las posiciones 2,3,6 bloqueadoras del receptor de la angiotensina ii. |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5290780A (enExample) |
| EP (1) | EP0497150B1 (enExample) |
| JP (1) | JP2758766B2 (enExample) |
| KR (1) | KR920014805A (enExample) |
| CN (1) | CN1037440C (enExample) |
| AT (1) | ATE164158T1 (enExample) |
| AU (2) | AU642573B2 (enExample) |
| CA (1) | CA2060154A1 (enExample) |
| CZ (1) | CZ281429B6 (enExample) |
| DE (1) | DE69224763T2 (enExample) |
| DK (1) | DK0497150T3 (enExample) |
| ES (1) | ES2117014T3 (enExample) |
| FI (1) | FI920217L (enExample) |
| GR (1) | GR3026592T3 (enExample) |
| HU (1) | HUT61748A (enExample) |
| IE (1) | IE920142A1 (enExample) |
| IL (1) | IL100711A0 (enExample) |
| NO (1) | NO920298L (enExample) |
| NZ (1) | NZ241343A (enExample) |
| PL (1) | PL293316A1 (enExample) |
| SK (1) | SK279004B6 (enExample) |
| TW (1) | TW282467B (enExample) |
| ZA (1) | ZA92392B (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290780A (en) * | 1991-01-30 | 1994-03-01 | American Cyanamid Co. | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| US5385894A (en) * | 1991-03-06 | 1995-01-31 | Merck & Co., Inc. | Disubstituted 6-aminoquinazolinones |
| DE69415706T2 (de) * | 1993-03-24 | 1999-05-20 | American Home Products Corp., Madison, N.J. | Substituierte Pyridopyrimidine als Antihypertensiva |
| US5358951A (en) * | 1993-04-23 | 1994-10-25 | American Cyanamid Company | Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones |
| US5610301A (en) * | 1993-07-01 | 1997-03-11 | American Cyanamid Company | Process for the regioselective n-alkylation of quinazolinones |
| US5342944A (en) * | 1993-07-19 | 1994-08-30 | American Cyanamid Company | Process for the preparation of 2-alkyl-3,5,6,7- or 8-substituted-4(3H)-quinazolinones |
| US5338736A (en) * | 1993-10-07 | 1994-08-16 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6-substituted quinazolinones |
| EP0782996B1 (en) * | 1994-09-20 | 1999-02-17 | Wakunaga Seiyaku Kabushiki Kaisha | Process for producing n-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same |
| US5760220A (en) * | 1995-06-07 | 1998-06-02 | American Home Products Corporation | Process for preparation of biphenyl derivatives |
| CA2223783A1 (en) * | 1995-06-07 | 1996-12-19 | Michel Bernatchez | Process for preparation of biphenyl derivatives |
| US5763608A (en) * | 1996-02-05 | 1998-06-09 | Hoechst Celanese Corporation | Process for preparing pyrimidine derivatives |
| US5739330A (en) * | 1996-02-05 | 1998-04-14 | Hoechst Celanese Corporation | Process for preparing quinazolones |
| US6638937B2 (en) | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| GB0223730D0 (en) * | 2002-10-11 | 2002-11-20 | Novartis Ag | Organic compounds |
| WO2004036870A2 (en) * | 2002-10-18 | 2004-04-29 | Koninklijke Philips Electronics N.V. | Method and system for metadata protection in tv-anytime |
| US20060052345A1 (en) * | 2002-11-04 | 2006-03-09 | Nps Pharmaceuticals, Inc. | Quinazolinone compounds as calcilytics |
| GB0412769D0 (en) * | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| AU2007303846B2 (en) * | 2006-10-04 | 2011-03-10 | Pfizer Products Inc. | Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists |
| CN101772513B (zh) | 2007-06-04 | 2013-11-13 | 协同医药品公司 | 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂 |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| WO2013186159A1 (en) | 2012-06-13 | 2013-12-19 | F. Hoffmann-La Roche Ag | New diazaspirocycloalkane and azaspirocycloalkane |
| HRP20191937T1 (hr) | 2012-09-25 | 2020-01-10 | F. Hoffmann - La Roche Ag | Derivati heksahidropirolo [3,4-c]pirola i srodni spojevi kao inhibitori autotaksina (atx) i kao inhibitori proizvodnje lizofosfatidne kiseline (lpa) za liječenje npr. bubrežnih bolesti |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| HK1220611A1 (zh) | 2013-03-15 | 2017-05-12 | Bausch Health Ireland Limited | 用於治疗胃肠道病症的组成物 |
| HRP20240805T1 (hr) | 2013-06-05 | 2024-09-27 | Bausch Health Ireland Limited | Ultra-pročišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i uporabe |
| RS56776B1 (sr) | 2013-11-26 | 2018-04-30 | Hoffmann La Roche | Derivati oktahidro-ciklobuta [1,2-c;3,4-c']dipirola kao inhibitori autotaksina |
| CA2935612A1 (en) | 2014-03-26 | 2015-10-01 | F. Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| UA118582C2 (uk) | 2014-03-26 | 2019-02-11 | Ф. Хоффманн-Ля Рош Аг | Біциклічні сполуки як інгібітори продукції аутотаксину (atx) і лізофосфатидилової кислоти (lpa) |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| CR20180058A (es) | 2015-09-04 | 2018-02-26 | Hoffmann La Roche | Nuevos derivados de fenoximetilo |
| EP3353180B1 (en) | 2015-09-24 | 2022-03-16 | F. Hoffmann-La Roche AG | Bicyclic compounds as atx inhibitors |
| PE20180552A1 (es) | 2015-09-24 | 2018-04-02 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca |
| BR112017026682A2 (pt) | 2015-09-24 | 2018-08-14 | Hoffmann La Roche | novos compostos bicíclicos como inibidores de dupla ação de atx/ca |
| EP3353176B1 (en) | 2015-09-24 | 2022-01-19 | F. Hoffmann-La Roche AG | Bicyclic compounds as atx inhibitors |
| EP3596060B1 (en) | 2017-03-16 | 2023-09-20 | F. Hoffmann-La Roche AG | New bicyclic compounds as atx inhibitors |
| BR112019019017A2 (pt) | 2017-03-16 | 2020-04-14 | Hoffmann La Roche | compostos heterocíclicos de utilidade como inibidores duplos de atx/ca |
| CN107056715B (zh) * | 2017-04-07 | 2019-07-30 | 江南大学 | 一种增强TRPV4-KCa2.3复合体耦联度的化合物及其在抗高血压中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607683D0 (en) * | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
| WO1988001270A1 (en) * | 1986-08-21 | 1988-02-25 | Pfizer Inc. | Pyridopyrimidinediones |
| CS272018B1 (en) * | 1988-11-01 | 1990-12-13 | Fisnerova Ludmila | Ethereal derivatives of 4/3h/-quinazolinone |
| CA2020073A1 (en) * | 1989-07-03 | 1991-01-04 | Eric E. Allen | Substituted quinazolinones as angiotensin ii antagonists |
| US5240928A (en) * | 1989-07-03 | 1993-08-31 | Merck & Co., Inc. | Substituted quinazolinones as angiotensin II antagonists |
| EP0407342A3 (en) * | 1989-07-06 | 1991-07-10 | Ciba-Geigy Ag | Pyrimidine derivatives |
| CA2037630C (en) * | 1990-03-07 | 2001-07-03 | Akira Morimoto | Nitrogen-containing heterocylic compounds, their production and use |
| CA2053148A1 (en) * | 1990-10-16 | 1992-04-17 | Karnail Atwal | Dihydropyrimidine derivatives |
| US5290780A (en) * | 1991-01-30 | 1994-03-01 | American Cyanamid Co. | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
-
1992
- 1992-01-14 US US07/818,721 patent/US5290780A/en not_active Expired - Lifetime
- 1992-01-16 DE DE69224763T patent/DE69224763T2/de not_active Expired - Fee Related
- 1992-01-16 EP EP92100640A patent/EP0497150B1/en not_active Expired - Lifetime
- 1992-01-16 DK DK92100640.9T patent/DK0497150T3/da active
- 1992-01-16 AT AT92100640T patent/ATE164158T1/de not_active IP Right Cessation
- 1992-01-16 ES ES92100640T patent/ES2117014T3/es not_active Expired - Lifetime
- 1992-01-17 IE IE014292A patent/IE920142A1/en not_active Application Discontinuation
- 1992-01-17 FI FI920217A patent/FI920217L/fi unknown
- 1992-01-20 ZA ZA92392A patent/ZA92392B/xx unknown
- 1992-01-20 IL IL100711A patent/IL100711A0/xx unknown
- 1992-01-21 NZ NZ241343A patent/NZ241343A/en unknown
- 1992-01-22 NO NO92920298A patent/NO920298L/no unknown
- 1992-01-22 AU AU10397/92A patent/AU642573B2/en not_active Ceased
- 1992-01-28 CA CA002060154A patent/CA2060154A1/en not_active Abandoned
- 1992-01-29 PL PL29331692A patent/PL293316A1/xx unknown
- 1992-01-29 JP JP4038746A patent/JP2758766B2/ja not_active Expired - Lifetime
- 1992-01-29 SK SK255-92A patent/SK279004B6/sk unknown
- 1992-01-29 CZ CS92255A patent/CZ281429B6/cs unknown
- 1992-01-30 CN CN92100545A patent/CN1037440C/zh not_active Expired - Fee Related
- 1992-01-30 HU HU9200278A patent/HUT61748A/hu unknown
- 1992-01-30 KR KR1019920001413A patent/KR920014805A/ko not_active Ceased
- 1992-01-31 TW TW081100762A patent/TW282467B/zh active
-
1993
- 1993-08-25 AU AU44906/93A patent/AU647992B2/en not_active Ceased
- 1993-10-29 US US08/145,458 patent/US5405849A/en not_active Expired - Lifetime
-
1998
- 1998-04-10 GR GR980400781T patent/GR3026592T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA92392B (en) | 1992-10-28 |
| US5405849A (en) | 1995-04-11 |
| GR3026592T3 (en) | 1998-07-31 |
| CN1066847A (zh) | 1992-12-09 |
| CS25592A3 (en) | 1992-08-12 |
| NO920298D0 (no) | 1992-01-22 |
| AU1039792A (en) | 1992-08-06 |
| AU642573B2 (en) | 1993-10-21 |
| HU9200278D0 (en) | 1992-04-28 |
| NZ241343A (en) | 1994-06-27 |
| PL293316A1 (en) | 1993-08-23 |
| CA2060154A1 (en) | 1992-07-31 |
| US5290780A (en) | 1994-03-01 |
| NO920298L (no) | 1992-07-31 |
| JPH0578332A (ja) | 1993-03-30 |
| JP2758766B2 (ja) | 1998-05-28 |
| IE920142A1 (en) | 1992-07-29 |
| EP0497150A1 (en) | 1992-08-05 |
| DK0497150T3 (da) | 1998-06-02 |
| EP0497150B1 (en) | 1998-03-18 |
| HUT61748A (en) | 1993-03-01 |
| TW282467B (enExample) | 1996-08-01 |
| ATE164158T1 (de) | 1998-04-15 |
| DE69224763T2 (de) | 1998-07-09 |
| FI920217A0 (fi) | 1992-01-17 |
| IL100711A0 (en) | 1992-09-06 |
| FI920217A7 (fi) | 1992-07-31 |
| DE69224763D1 (de) | 1998-04-23 |
| KR920014805A (ko) | 1992-08-25 |
| SK279004B6 (sk) | 1998-05-06 |
| CN1037440C (zh) | 1998-02-18 |
| AU4490693A (en) | 1993-11-18 |
| CZ281429B6 (cs) | 1996-09-11 |
| FI920217L (fi) | 1992-07-31 |
| AU647992B2 (en) | 1994-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2117014T3 (es) | Quinazolinonas substituidas en las posiciones 2,3,6 bloqueadoras del receptor de la angiotensina ii. | |
| MX9204737A (es) | Acidos imidazolil-alquenoicos | |
| MX9300842A (es) | Antagonistas de endotelina de sulfonamida. | |
| ES2063734T3 (es) | Imidazoles bloqueantes de receptores de angiotensina ii. | |
| MXPA04004492A (es) | Indazolilpirrolotriazinas c-5 modificadas. | |
| NO20052733L (no) | C-6 modifiserte indazolylpyrrolotriaziner | |
| ES2178676T3 (es) | Compuestos de pirimidina substituidos y su empleo. | |
| BRPI0418231A (pt) | compostos de pirrolotriazina como inibidores da cinase | |
| ATE211743T1 (de) | Substituierte 3-aminochinuclidine | |
| MY134848A (en) | Pyrrolo[2,1-f] [1,2,4] triazine inhibitors of kinases | |
| MY128370A (en) | Pyrrolotriazane inhibitors of kinases | |
| ES2167571T3 (es) | Terapia de combinacion de antagonista de aldosterona epoxi-esteroideo y antagonista de angiotensina ii para el tratamiento del fallo cardiaco congestivo. | |
| ES2196063T3 (es) | Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales. | |
| DE69034103D1 (de) | Imidazoalkensäure | |
| ECSP941135A (es) | Antagonistas triciclicos de vasopresina de benzacepina | |
| ES2150113T3 (es) | Derivados de pirazol y procedimientos para la preparacion de los mismos. | |
| ES2084702T3 (es) | Imidazoles sustituidos utiles como inhibidores de la angiotensina ii. | |
| ES2188649T3 (es) | Fenil-alquil-imidazoles como antagonistas del receptor h3. | |
| ES2180338T3 (es) | Antagonistas del receptor de crf y metodos relacionados. | |
| BR0110247A (pt) | Derivado de ciclohexilamina como antagonistas de receptor de nmda seletivos em subtipo | |
| ATE119524T1 (de) | Substituierte n-(imidazolyl)alkyl-alanin- derivate. | |
| BR0111301A (pt) | Cicloexilaminas bicìclicas e seu uso como antagonistas de receptor de nmda | |
| DE60112574D1 (de) | Bicyclische cyclohexylamine und ihre verwendung als nmda-rezeptor antagonisten | |
| DE602005023732D1 (de) | Pyrrolotriazinverbindungen | |
| DK0612524T3 (da) | Angiotensin II antagonister til behandling af virussygdomme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 497150 Country of ref document: ES |